{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:02:13Z","timestamp":1792738933238,"version":"4.5.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015559","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T18:42:46Z","timestamp":1293043366000},"page":"e15559","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":259,"title":["Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza"],"prefix":"10.1371","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct00984945","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Nathalie","family":"Landry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Tr\u00e9panier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Dargis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-P.","family":"V\u00e9zina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"ref1","year":"2009"},{"key":"ref2","year":"2007"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"8131","DOI":"10.1128\/JVI.00534-09","article-title":"Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment.","volume":"83","author":"S Jackson","year":"2009","journal-title":"J of Virology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1073\/pnas.0912807107","article-title":"Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence.","volume":"107","author":"C Li","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","first-page":"1","article-title":"The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza.","volume":"8","author":"MA D'Aoust","year":"2010","journal-title":"Plant Biotechnology Journal"},{"key":"ref6","first-page":"930","article-title":"Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal challenge in mice.","volume":"6","author":"MA D'Aoust","year":"2010","journal-title":"Plant Biotechnology Journal"},{"key":"ref7","first-page":"193","article-title":"Application of an improved single-radial immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunits influenza vaccines.","volume":"39","author":"J Wood","year":"1997","journal-title":"Dev Biol Stand"},{"key":"ref8","first-page":"493","article-title":"\u201cA simple method of estimating fifty percent endpoints\u201d.","volume":"27","author":"LJ Reed","year":"1938","journal-title":"The American Journal of Hygiene"},{"key":"ref9","year":"2002"},{"key":"ref10","year":"2008"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/592172","article-title":"Safety and immunogenicity of an inactivated influenza A\/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.","volume":"198","author":"WA Keitel","year":"2008","journal-title":"JID"},{"key":"ref12","first-page":"43","article-title":"Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza.","volume":"52","author":"GC Schild","year":"1975","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","article-title":"Detection of avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.","volume":"37","author":"T Rowe","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1128\/IAI.38.2.530-535.1982","article-title":"Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions. .","volume":"38","author":"BL Lu","year":"1982","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"G9","DOI":"10.1016\/j.vaccine.2009.10.010","article-title":"A risk-benefit analysis of vaccination.","volume":"27","author":"U Heininger","year":"2009","journal-title":"Vaccine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/glycob\/cwg024","article-title":"Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.","volume":"13","author":"M Bardor","year":"2003","journal-title":"Glycobiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000096114","article-title":"The role of glycosylation in allergy.","volume":"142","author":"F Altmann","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"issue":"45","key":"ref18","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1016\/j.vaccine.2009.06.090","article-title":"Antibody quantity versus quality after influenza vaccination.","volume":"27","author":"J Feng","year":"2009","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(06)68656-X","article-title":"Safety and immunogenicity of an inactivated split-virion influenza A\/Vietnam\/1194\/2004 (H5N1) phase I randomised trial.","volume":"367","author":"JL Bresson","year":"2006","journal-title":"The Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.","volume":"197","author":"DI Berstein","year":"2008","journal-title":"JID"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.vaccine.2008.05.077","article-title":"Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.","volume":"26","author":"TM Nolan","year":"2008","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.","volume":"368","author":"J Lin","year":"2006","journal-title":"The Lancet"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1056\/NEJMoa073121","article-title":"A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.","volume":"358","author":"HJ Ehrlich","year":"2008","journal-title":"N Eng J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e4384","DOI":"10.1371\/journal.pone.0004384","article-title":"MF59\u00ae- adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults.","volume":"4","author":"A Banzhoff","year":"2009","journal-title":"PloS One"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination.","volume":"103","author":"C Hannoun","year":"2004","journal-title":"Virus Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model.","volume":"10","author":"L Coudeville","year":"2010","journal-title":"BMC Medical research Methodology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1086\/590913","article-title":"An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe immunogenic, and induces cross-reactive immune responses in healthy adults.","volume":"198","author":"K Levie","year":"2008","journal-title":"JID"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00063030-200822050-00001","article-title":"Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandri\u2122]: A review of its use as an active immunization against influenza A subtype H5N1 virus.","volume":"22","author":"NJ Carter","year":"2008","journal-title":"Biodrugs"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T19:21:52Z","timestamp":1592162512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015559"}},"subtitle":[],"editor":[{"given":"Ron A. M.","family":"Fouchier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015559","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}